Diagnostic Imaging Devices are used for the visualization of structural and functional patterns of organs or tissues. Angio Suites are multi-purpose examination rooms, where diverse angio/interventional interventions are performed. GlobalData uses proprietary data and analytics to provide a comprehensive report on the angio suites devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the angio suites market in Australia was Siemens Healthineers followed by GE HealthCare Technologies, Philips Healthcare Informatics, Shimadzu and Canon Medical Systems.
Interventions performed in these include angioplasty, therapeutic stenting, obstruction bypasses, intravascular therapy, angiograms, myelograms, vertebroplasty and surgery-free removal of tissue specimens. A typical Angio Suites includes: X-ray generator, image intensifier (mostly C-Arms), and a rotating table top for easy patient positioning and movement. This category includes Single Plane Angio Suites and Biplane Angio Suites. Single Plane Angio Suites provides two-dimensional view of the anatomy and are configured with one imaging positioner. Biplane Angio Suites involves the use of two simultaneous angiographic views at right angles to provide a three dimensional view of the anatomy and are configured with two imaging positioners.
The value of the angio suites devices market within Australia was expected to be over $60m in 2023.
For the latest complete market share analysis of angio suites device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
